A recent discovery led by Helmholtz Munich researchers from the Type 1 Diabetes Immunology Research Unit has uncovered how regulatory immune T-cells (called Tregs) interplay and control metabolic tissues. The new findings published in Cell…
A collaborative research project between scientists from Helmholtz Munich, Goethe University Frankfurt, Ludwig Maximilian University Munich, and Technion, the Israel Institute of Technology in Haifa, on “Understanding and Targeting…
The Dynamic Journey of DNA Replication Timing and Its Impact on Cellular Plasticity
The intricate process of duplicating genetic information, referred to as DNA replication, lies at the heart of the transmission of life from one cell to another…
2023 has changed the way we treat obesity. A new class of drugs, mimicking a gut hormone called glucagon-like peptide-1 (GLP-1), is reshaping medicine and improving many people’s lives globally. GLP-1 drugs do not only induce significant weight loss,…
At this year’s Conference of the Lipedema Society (LipödemGesellschaft e. V.) HI-MAG PostDoc Pamela Nono Nankam received the society’s Science Award. The Annual Conference was held from October 27th and 28th, 2023 in the city hall of Flörsheim/Main.
Changes in small blood vessels are a common consequence of diabetes development. Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have now developed a method that can be used to measure these microvascular changes in the…
Awards & Grants, HI-MAG,
Awards & Grants,
Awards & Grants, Bioengineering, IBMI,
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: